Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/18/2003WO2003075855A2 Antibodies against cancer antigen tmeff2 and uses thereof
09/18/2003WO2003075854A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003075839A2 Methods of inducing terminal differentiation
09/18/2003WO2003075838A2 Methods and compositions for pharmacological and toxicological evaluation of test agents
09/18/2003WO2003075835A2 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
09/18/2003WO2003075833A2 Screening method for orthopoxvirus antivirals
09/18/2003WO2003075765A1 Biospecific contrast agents
09/18/2003WO2003075751A2 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics
09/18/2003WO2003075745A2 Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry
09/18/2003WO2003075742A2 Biomarker for efficacy of appetite suppressant drugs
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003062468A3 Method for binding site identification using a multi-scale approach
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003057851A3 Binding proteins as biosensors
09/18/2003WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
09/18/2003WO2003054159A3 Modulating insulin receptor signaling through targeting facl
09/18/2003WO2003048735A3 Processes for the measurement of the potency of glatiramer acetate
09/18/2003WO2003038443A3 Noe-nmr based methods for the identifycation of compounds which can bind to membrane receptors
09/18/2003WO2003038056A3 Methods for inhibiting lentivirus replication
09/18/2003WO2003036303A8 Diagnostic method
09/18/2003WO2003031584A3 Axon repair
09/18/2003WO2003030817A3 Antibody complexes and methods for immunolabeling
09/18/2003WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
09/18/2003WO2003024442A3 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
09/18/2003WO2003023389A9 Solid electrochemical sensor
09/18/2003WO2003022878A3 Subunit respiratory syncytial virus vaccine preparation
09/18/2003WO2003020974A3 Methods for detecting dna originating from different individuals in one sample
09/18/2003WO2003016899A3 Method and system for detection of hydrocarbon species in a gas
09/18/2003WO2002103015A3 Abca10 transporter
09/18/2003WO2002100901A3 Determination of bone-sialoprotein in bodily fluids for oncological problems
09/18/2003WO2002099423A3 Method for determining an analyte
09/18/2003WO2002099382A3 Multiplexing method
09/18/2003WO2002097389A3 Device for collecting liquid samples
09/18/2003WO2002097125A3 Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002095400A3 Methods for identifying receptor up- and downmodulators
09/18/2003WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
09/18/2003WO2002088744A3 Diagnosis of physiological conditions by proteomic characterization
09/18/2003WO2002085410A3 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls
09/18/2003WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002073189A3 Method and apparatus for on-line monitoring of quality and/or condition of highly resistive fluids
09/18/2003WO2002072790A3 Tsg101-gag interaction and use thereof
09/18/2003WO2002071071A3 Assays involving reporter systems on carriers
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002061434A3 Anergy-regulated molecules
09/18/2003WO2002056021A3 Polymer brushes for immobilizing molecules to a surface
09/18/2003WO2002050609A3 Electrochemical test strip cards that include an integral dessicant
09/18/2003WO2002048701A9 Nanosensors
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003WO2002032455A3 Vaccine
09/18/2003WO2002030571A3 Surface adsorbing polymers and the uses thereof to treat hydrophobic or hydrophilic surfaces
09/18/2003WO2002027321A9 Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
09/18/2003WO2002025284A3 High-throughput assays for the proteolytic activities of clostridial neurotoxins
09/18/2003WO2002006536A3 Methods and compositions for perioperative genomic profiling
09/18/2003US20030177525 Determination nematode resistance; soybean seeds
09/18/2003US20030177511 Antitumor, anticancer agents
09/18/2003US20030177380 Devices for storing array data and methods of using the same
09/18/2003US20030177143 Modular bioinformatics platform
09/18/2003US20030176992 Visualization method of RNA pseudoknot structures
09/18/2003US20030176981 Method for predicting flow properties of powders
09/18/2003US20030176978 System and method for simulating cellular biochemical pathways
09/18/2003US20030176977 System and method for simulating cellular biochemical pathways
09/18/2003US20030176976 Bioinformatics system architecture with data and process integration for overall portfolio management
09/18/2003US20030176973 Determining the viscosity of a hydrocarbon reservoir fluid
09/18/2003US20030176929 User interface for a bioinformatics system
09/18/2003US20030176805 Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient
09/18/2003US20030176803 Personal breath tester
09/18/2003US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176680 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
09/18/2003US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176666 Hypothalamus-specific polypeptides
09/18/2003US20030176665 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
09/18/2003US20030176662 Blocking binding to hepatitis virus; therapy for infection; drug design using computers
09/18/2003US20030176661 Novel antibody with specificity for colon cancer
09/18/2003US20030176651 Multiprotein-complex comprising a nmda receptor and uses thereof
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176648 Ion channel
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030176644 Compositions and methods for molecular biology
09/18/2003US20030176373 Agents that modulate DNA-PK activity and methods of use thereof
09/18/2003US20030176343 Administering to the subject an amount of topors (protein) effective to inhibit the uncontrolled proliferation for therapy
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176340 For therapy of renal failure
09/18/2003US20030176338 Novel serine-threonine kinase
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176333 Contacting the compound with a CASPR3 polypeptide, polypeptide encoded by a nucleic acid that hybridizes under stringent conditions to a nucleic acid encoding a polypeptide; determining functional effect of the compound upon the CASPR3
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030176330 55562 and 21617, novel human proteins and methods of use thereof
09/18/2003US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha
09/18/2003US20030176315 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction
09/18/2003US20030176183 Blood glucose tracking apparatus and methods
09/18/2003US20030175995 Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
09/18/2003US20030175994 Geometrically efficient particle agglutination, particularly to detect low affinity
09/18/2003US20030175993 Ketone assay
09/18/2003US20030175992 Quantatitive analysis; measuring concentration of glucose in sample
09/18/2003US20030175991 Optically-assisted high precision pregnancy progress monitoring
09/18/2003US20030175988 Measurement of spectra properties; coupling to fluorecent dye
1 ... 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 ... 3937